HomeCompareBNGOW vs DGRO

BNGOW vs DGRO: Dividend Comparison 2026

BNGOW yields 55555.56% · DGRO yields 2.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BNGOW wins by $1.3694488476474725e+24M in total portfolio value
10 years
BNGOW
BNGOW
● Live price
55555.56%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.3694488476474725e+24M
Annual income
$1,364,616,913,224,020,300,000,000,000,000.00
Full BNGOW calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.10%
Share price
$70.18
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$235.38
Full DGRO calculator →

Portfolio growth — BNGOW vs DGRO

📍 BNGOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBNGOWDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BNGOW + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BNGOW pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNGOW
Annual income on $10K today (after 15% tax)
$4,722,222.22/yr
After 10yr DRIP, annual income (after tax)
$1,159,924,376,240,417,200,000,000,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$178.14/yr
After 10yr DRIP, annual income (after tax)
$200.07/yr
At 15% tax rate, BNGOW beats the other by $1,159,924,376,240,417,200,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNGOW + DGRO for your $10,000?

BNGOW: 50%DGRO: 50%
100% DGRO50/50100% BNGOW
Portfolio after 10yr
$6.847244238237362e+23M
Annual income
$682,308,456,612,010,100,000,000,000,000.00/yr
Blended yield
99.65%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNGOW buys
0
DGRO buys
0
No recent congressional trades found for BNGOW or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBNGOWDGRO
Forward yield55555.56%2.10%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.3694488476474725e+24M$31.6K
Annual income after 10y$1,364,616,913,224,020,300,000,000,000,000.00$235.38
Total dividends collected$1.3691317625593198e+24M$2.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BNGOW vs DGRO ($10,000, DRIP)

YearBNGOW PortfolioBNGOW Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$5,566,256$5,555,555.56$11,290$209.57+$5.55MBNGOW
2$2,896,015,891$2,890,059,997.69$12,722$213.54+$2896.00MBNGOW
3$1,408,372,313,122$1,405,273,576,118.65$14,314$217.18+$1408372.30MBNGOW
4$640,202,141,193,643$638,695,182,818,602.40$16,080$220.53+$640202141.18MBNGOW
5$272,022,320,879,523,800$271,337,304,588,446,620.00$18,040$223.59+$272022320879.51MBNGOW
6$108,040,039,048,992,300,000$107,748,975,165,651,200,000.00$20,215$226.40+$108040039048992.28MBNGOW
7$40,110,958,331,298,180,000,000$39,995,355,489,515,755,000,000.00$22,627$228.96+$40110958331298176.00MBNGOW
8$13,920,190,362,947,560,000,000,000$13,877,271,637,533,070,000,000,000.00$25,302$231.31+$13920190362947559424.00MBNGOW
9$4,515,826,563,973,900,600,000,000,000$4,500,931,960,285,546,600,000,000,000.00$28,268$233.44+$4.5158265639739007e+21MBNGOW
10$1,369,448,847,647,472,600,000,000,000,000$1,364,616,913,224,020,300,000,000,000,000.00$31,557$235.38+$1.3694488476474725e+24MBNGOW

BNGOW vs DGRO: Complete Analysis 2026

BNGOWStock

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Full BNGOW Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this BNGOW vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNGOW vs SCHDBNGOW vs JEPIBNGOW vs OBNGOW vs KOBNGOW vs MAINBNGOW vs VIGBNGOW vs NOBLBNGOW vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.